2026 NPPES data Hematology & Oncology Physician NPI 1184358699 MD
Verify on CMS →

Anuoluwa Oyetoran, MD

Hematology & Oncology Physician in Royal Oak, Michigan.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,232 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
113
Medicare Part D claims · 26 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
90%
generic claims · 10% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$174.53
3 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Anuoluwa Oyetoran, MD filed 113 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in Royal Oak, Michigan, prescribing 90% generic.

113
Part D claims, 2023
90%
generic prescribing
$174.53
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Anuoluwa Oyetoran, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

113 35th percentile higher than 35% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic, not verified)

Anuoluwa Oyetoran, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Anuoluwa Oyetoran, MD?

Quality data not reported

NPI registry status

Active

Issued 07/11/2022

NPI 1184358699

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,232 US NPIs in this specialty

Medicare Part D claims

113 87% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in Michigan

How Hematology & Oncology Physician compares to other specialties among Michigan providers

Michigan providers
Behavior Technician - 21.4%Behavior Technician21.4%Clinical Social Worker - 5.8%Clinical Social Worker5.8%Student in an Organized Health Care Education/Training Program - 3.6%Student in an Organized Health Care Education/Training Program3.6%Physical Therapist - 3.4%Physical Therapist3.4%Social Worker - 3.4%Social Worker3.4%Pharmacist - 3%Pharmacist3%Hematology & Oncology Physician - 0.1%Hematology & Oncology Physician0.1%
Largest specialties in Michigan (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Anuoluwa Oyetoran, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 3601 W 13 MILE RD, Royal Oak, MI, 48073, with a listed phone of (248) 551-3850. NPI 1184358699 was issued on 07/11/2022.

Medicare Part D records for calendar year 2023 show 113 prescription claims written by this provider, covering 26 Medicare beneficiaries and totaling roughly $6K in drug spend, split 10% brand-name and 90% generic by claim count.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,232 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

3601 W 13 MILE RD
Royal Oak, MI 48073

Provider Details

NPI 1184358699
Specialty Hematology & Oncology Physician
Credentials MD
Gender Female
NPI Issued 07/11/2022

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Anuoluwa Oyetoran, MD. Source: openpaymentsdata.cms.gov.

Total received

$175

Largest payer

ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - Michigan MI-BOM 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 - they are NOT specific to Anuoluwa Oyetoran, MD. To verify Anuoluwa Oyetoran, MD's current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

123
Total board actions, Michigan 2023
Across 120 cases
3.00
Actions per 1,000 licensees
Michigan statewide rate
probation
Most common action type
44 cases

MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

Anuoluwa Oyetoran, MD - brand share 10.0%
Hematology & Oncology Physician average

10% brand-name claims vs 90% generic, on 113 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

113
Total Claims
$6K
Total Drug Cost
26
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
232
Total Day Supply
6,406
Brand vs Generic
10% brand / 90% generic
Brand Drug Cost
$5K
Generic Drug Cost
$2K
Antibiotic Claims
16

Patient Demographics

Average Patient Age
72.2 years
Avg HCC Risk Score
2.30

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Atorvastatin Calcium
15

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How Anuoluwa Oyetoran, MD fits within the Hematology & Oncology Physician landscape nationally.

11,232
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

Anuoluwa Oyetoran, MD's 113 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Michigan

Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as Oyetoran.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Michigan medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Anuoluwa Oyetoran, MD's specialty?
Anuoluwa Oyetoran, MD specializes in Hematology & Oncology Physician and practices in Royal Oak, Michigan. Credentials: MD.
How much does Anuoluwa Oyetoran, MD prescribe under Medicare Part D?
In 2023, Anuoluwa Oyetoran, MD wrote 113 Medicare Part D claims totaling $6K in drug costs for 26 beneficiaries.
Where is Anuoluwa Oyetoran, MD located?
Anuoluwa Oyetoran, MD is located at 3601 W 13 MILE RD, Royal Oak, MI, 48073. Phone: (248) 551-3850.
What is Anuoluwa Oyetoran, MD's NPI number?
Anuoluwa Oyetoran, MD's National Provider Identifier (NPI) is 1184358699, issued on 07/11/2022.
Does Anuoluwa Oyetoran, MD prescribe more brand-name or generic drugs?
Anuoluwa Oyetoran, MD's prescribing is 10% brand-name and 90% generic drugs by claim count, with $5K in brand drug costs.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,232 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Anuoluwa Oyetoran, MD prescribe most often?
Based on 2023 Medicare Part D data, Anuoluwa Oyetoran, MD's most frequently prescribed drugs include Atorvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Anuoluwa Oyetoran, MD accept Medicare?
Anuoluwa Oyetoran, MD appears in CMS Medicare data with 113 Part D claims and 26 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Anuoluwa Oyetoran, MD's credentials?
Anuoluwa Oyetoran, MD's NPI is 1184358699 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.